Trademark Search in Canada

RECURSION CANADA

View On IC.GC.CA

REGISTERED

on 1 Mar 2024

Last Applicant/ Owned by

RECURSION PHARMACEUTICALS INC.

41 South Rio Grande StreetSalt Lake City, UT 84101

Serial Number

2110371 filed on 28^th May 2021

Registration Number

TMA1223633 registered on 1^st Mar 2024

Registration expiry Date

1^st Mar 2034

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

M5H3S5

RECURSION CANADA

Trademark usage description

computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious Read More

Classification Information

Class [009]
Computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases.

Classification kind code

Class [042]
Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; drug use discovery services; scientific and technological services namely, medical research laboratory services, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases.

Classification kind code

Mark Details

Serial Number

2110371

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 13^th Dec 2023	Advertised
Submitted for opposition 27 on 16^th Nov 2023	Approval Notice Sent
Submitted for opposition 26 on 16^th Nov 2023	Approved
Submitted for opposition 67 on 7^th Oct 2022	Agent Name Changed
Submitted for opposition 22 on 15^th Sept 2022	Search Recorded
Submitted for opposition 20 on 15^th Sept 2022	Examiner's First Report
Submitted for opposition 287 on 5^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 28^th May 2021	Filed
Submitted for opposition 1 on 28^th May 2021	Created
Submitted for opposition 31 on 28^th May 2021	Formalized